ストックスクリーナーアプリを入手
38.98
0.26%
-0.095
前日終値:
$39.07
開ける：
$39.12
24時間の取引高:
50,116
Relative Volume:
0.43
時価総額：
$428.85M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+6.53%
1か月 パフォーマンス:
+56.51%
6か月 パフォーマンス:
+150.61%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$37.33
$39.13
1週間の範囲:
$34.57
$39.40
52週間の値動き範囲:
$11.17
$40.50
Palvella Therapeutics Inc Stock (PVLA) Company Profile
PVLA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PVLA
Palvella Therapeutics Inc
|
38.79 | 414.81M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
377.71 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.66 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.63 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
668.20 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.01 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-04-09 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-26 | 開始されました | Stifel | Buy |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2025-02-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-02-05 | 開始されました | TD Cowen | Buy |
| 2024-12-26 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-03-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | 開始されました | Robert W. Baird | Outperform |
| 2018-03-19 | 開始されました | Evercore ISI | Outperform |
| 2018-03-19 | 開始されました | Jefferies | Buy |
| 2018-01-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-30 | 開始されました | Rodman & Renshaw | Buy |
| 2016-08-05 | 再開されました | ROTH Capital | Buy |
| 2015-08-12 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-07-27 | 開始されました | Oppenheimer | Outperform |
| 2015-07-22 | 開始されました | ROTH Capital | Buy |
すべてを表示
Palvella Therapeutics Inc (PVLA) 最新ニュース
Palvella Therapeutics Q2 2025 Earnings Call Scheduled for August 14 | PVLA Stock News - Stock Titan
Palvella Therapeutics CEO to Speak at Canaccord Genuity Growth Conference - MSN
Palvella Therapeutics Inc. stock volume spike explainedGrowth Watchlist for Long Term Positioning - Newser
Analysts Set Expectations for PVLA Q2 Earnings - Defense World
How to read the order book for Palvella Therapeutics Inc.AI Trade Signal Forecast with Chart Logic - Newser
How hedge fund analytics apply to Palvella Therapeutics Inc. stockCapital Growth Plan for New Investors - Newser
What makes Palvella Therapeutics Inc. stock price move sharplyHigh Yield Signals with Entry Timing - Newser
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
What institutional flow reveals about Palvella Therapeutics Inc.Predictive Analytics for Equity Growth Potential - Newser
Palvella Therapeutics (NASDAQ:PVLA) Rating Increased to Strong-Buy at Lifesci Capital - Defense World
Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
What indicators show strength in Palvella Therapeutics Inc.Weekly Outlook for Short Term Investors - Newser
Palvella Therapeutics Inc. stock trend forecastAI Intraday Market Movement Prediction Tool - Newser
Raymond James Initiates Palvella Therapeutics(PVLA.US) With Buy Rating, Announces Target Price $54 - 富途牛牛
Raymond James initiates Palvella Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada
Lifesci Capital Upgrades Palvella Therapeutics (NASDAQ:PVLA) to Strong-Buy - Defense World
Palvella Therapeutics CEO to Share Rare Disease Pipeline Updates at Major Growth Conference - Stock Titan
Palvella Therapeutics (NASDAQ:PVLA) Stock Rating Upgraded by Lifesci Capital - Defense World
Does Palvella Therapeutics Inc. fit your quant trading modelFree Real Trader Watchlist of Hot Stocks - Newser
Exit strategy if you’re trapped in Palvella Therapeutics Inc.Free Daily Smart Money Movement Monitor - Newser
Palvella Therapeutics Inc. Shows Risk Reward Favoring UpsideEntry Plan for Oversold Reversal Stocks Released - metal.it
Analysts Initiate Coverage on Akero Therapeutics, AeroVironment, Wave Life Sciences, Palvella Therapeutics, and WeRide Inc. - AInvest
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Will Palvella Therapeutics Inc. stock split in the near futureFree Step-by-Step Stock Investment Guide - Newser
Real time scanner hits for Palvella Therapeutics Inc. explainedDaily Pattern Analysis with Return Forecast - Newser
Is it the right time to buy Palvella Therapeutics Inc. stockBuild wealth steadily with proven stock picks - Jammu Links News
Is Palvella Therapeutics Inc. stock overvalued or undervaluedAccess high-yield investment alerts now - Jammu Links News
What are analysts’ price targets for Palvella Therapeutics Inc. in the next 12 monthsUnlock steady growth with low-risk stocks - Jammu Links News
Will Palvella Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsReal-Time Setup Summary with ROI Focus - Newser
When is Palvella Therapeutics Inc. stock expected to show significant growthFree Trend-Following Techniques - Jammu Links News
Should I hold or sell Palvella Therapeutics Inc. stock in 2025Outstanding capital returns - Jammu Links News
How strong is Palvella Therapeutics Inc. company’s balance sheetUnlock real-time trading signals for gains - Jammu Links News
Is Palvella Therapeutics Inc. a growth stock or a value stockCapitalize on emerging investment opportunities - Jammu Links News
What catalysts could drive Palvella Therapeutics Inc. stock higher in 2025Maximize returns with timely market signals - Jammu Links News
What is the risk reward ratio of investing in Palvella Therapeutics Inc. stockMaximize portfolio growth with expert advice - Jammu Links News
What analysts say about Palvella Therapeutics Inc. stockBuild a winning investment strategy - Jammu Links News
What institutional investors are buying Palvella Therapeutics Inc. stockDiscover the next big stock winners - Jammu Links News
What are the latest earnings results for Palvella Therapeutics Inc.Unstoppable investment returns - Jammu Links News
Tools to assess Palvella Therapeutics Inc.’s risk profileRisk Aware Trading Ideas with Alert Levels - Newser
Palvella Therapeutics Inc (PVLA) 財務データ
Palvella Therapeutics Inc (PVLA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.14%
0.27%
大文字化:
|
ボリューム (24 時間):